期刊文献+

VEGF及FLT-1在结直肠癌中的表达及临床意义 被引量:1

Expression and clinical significance of VEGF and FLT-1 in colorectal carcinoma
下载PDF
导出
摘要 目的探讨血管内皮生长因子(VEGF)及其受体FLT-1在直肠癌组织中的表达及其临床病理意义。方法采用免疫组织化学法分别检测82例直肠癌组织中VEGF及其受体FLT-1蛋白的表达,并分析其相关性及临床意义。结果 VEGF在直肠癌组织中阳性表达率为71.9%(59/82),FLT-1在直肠癌组织中的阳性表达率为81.7%(67/82)。VEGF表达与直肠癌淋巴结转移和Duke's分期有关有关(P<0.05)。FLT-1表达与浸润深度和淋巴结转移有关(P<0.05)。VEGF及FLT-1蛋白在直肠癌组织中的表达呈正相关(P<0.05)。结论 VEGF及其受体FLT-1的表达与直肠癌的侵袭和转移有密切关系,值得进一步研究。 Objective To investigate the expression of VEGF and FLT-1 proteins in colorectal carcinoma and analyze their clinicopathological significance. Methods The expression of VEGF and FLT-1 proteins was detected by immunohisto-chemistry in 82 colorectal carcinoma specimens,and the correlation and clinical significance of which were analyzed. Results The positive rates of VEGF protein expression in colorectal carcinoma were 71. 9%(59/82),and the positive rates of FLT-1 were 81. 7%(67/82). The expression of VEGF proteins was found to be associated with lymph node metastasis and Dukes stage in colorectal carcinoma(P&lt;0. 05),and the expression of FLT-1 was associated with depth of infiltration and lymphnode metastasis(P&lt;0. 05). A positive correlation was noted between the expression of VEGF and FLT-1 in colorectal carcinoma (r=0. 565,P&lt;0. 05). Conclusion The expression of VEGF and its receptor FLT-1 is closely associated with the invasion and metastasis of colorectal cancer ,which is worthy of further study.
出处 《临床合理用药杂志》 2014年第17期14-15,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 结直肠癌 血管内皮生长因子 fms样酪氨酸激酶1 免疫组织化学 Colorectal carcinoma Vascular endothelial growth factor Immunohistochemis-try
  • 相关文献

参考文献3

二级参考文献16

  • 1高国林,杨思凤,宋刚,徐秀勤,潘伯荣.血管内皮细胞第Ⅷ因子在胃癌间质血管的研究[J].新消化病学杂志,1994,2(1):30-31. 被引量:4
  • 2Helfrich I, Edler L, Sucker A, et al. Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma[J]. Clin Cancer Res,2009,15(4):1384-1392.
  • 3Chung YC, Hou YC,Chang CN, et al. Expression and prognostic significance of angiopoietin in colorectal carcinoma [J]. J Surg Oncol, 2006,94 (7): 631-638.
  • 4Birner P, Schindl M,Obermair A, et al. Overexpression of Hypoxia-inducihle Factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer[J]. Cancer Res, 2000,6(1(17): 4693-4696.
  • 5Weidner N, Carroll PR, Flax J, et al. Tumor angiogenesis correlates with metastasis in invasive prostate careinoma[J]. Am J Pathol, 1993,143(2) : 401-409.
  • 6Mooteri S, Rubin D, Leurgans S, et al. Tumor angiogenesis in primary and metastatic colorectal cancers[J]. Dis Colon Rectum, 1996,39(10): 1073-1080.
  • 7Alexandrakis MG,Passam FH,Sfiridaki A, et al. Elevated serum angiogenin in muhiple myeloma [J]. Hematol J, 2003, 4 (6) :454-455.
  • 8Ahmad SA, Liu W,Jung YD. Differential expression of angiopoietin-1 and angiopoietin-2 in colon caicinoma. A possible mechanism for the initiation of angiogenesis[J]. Cancer, 2001, 92(5): 1138-1143.
  • 9Dallas NA, Samuel S, Xia L, et al. Endoglin(CD105) : a marker of tumor vasculature and potential target for therapy[J]. Clin Cancer Res, 2008,14 (7) : 1931 - 1937.
  • 10Sarraf-Yazdi S, Mi J, Moeller BJ, et al. Inhibition of in vivo tumor angio genesis and growth via systemic delivery of an angiopoietin2-Specific RNA aptamer[J]. J Surg Res, 2008, 146 (1):16-23.

共引文献58

同被引文献29

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部